Sanofi is a French multinational healthcare company. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication.

Top 100 largest companies in Russia by revenue

Top 100
Revenue(RF), mln.USD
Assets(RF), mln.USD
Capital(RF), mln.USD
Glob.Revenue, mln.USD
Staff(RF), 2021
Taxes(RF), mln.USD

In October 2009, Sanofi-Aventis bought a 74 percent stake in insulin manufacturer Bioton Vostok. This enterprise, located in Orel, was named Sanofi-Aventis Vostok and specializes in the production of insulins.

The Company Statement
October 18, 2023

The company promised to stop any new spending not related to the supply of the essential and life-changing medicines and vaccines in Russia, as well as in Belarus. Increased revenue, profit and assets in Russia in 2022 vs 2021. Customs data shows that the latest deliveries were in 2023. Sanofi experiencing serious supply problems from its Russian plant to EU market.

December 06, 2023Sanofi experiencing serious supply problems from its Russian plant to EU market
November 07, 2023Sanofi cannot supply insulin from the Oryol plant to Europe
February 24, 2023Russia Search / ImportGenius | International Trade Databases for Import-Export Businesses
June 23, 2022Sanofi response to the situation in Ukraine
JSC "SANOFI VOSTOK" - Oryol region - JSC "SANOFI VOSTOK" - General Director Shilov M.V. - Taxpayer Identification Number 5751028489
JSC "SANOFI RUSSIA" - Moscow - General Director Simakova A. N. - Taxpayer Identification Number 7705018169
LLC "OPELLA HEALTHCARE" - Moscow - General Director Romanova I. G. - Taxpayer Identification Number 9710085580
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.